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A method to rapidly create protein aggregates in
living cells
Yusuke Miyazaki1, Kota Mizumoto2,w, Gautam Dey1,w, Takamasa Kudo1, John Perrino3, Ling-chun Chen1,
Tobias Meyer1 & Thomas J. Wandless1
The accumulation of protein aggregates is a common pathological hallmark of many
neurodegenerative diseases. However, we do not fully understand how aggregates are formed
or the complex network of chaperones, proteasomes and other regulatory factors involved in
their clearance. Here, we report a chemically controllable ﬂuorescent protein that enables us
to rapidly produce small aggregates inside living cells on the order of seconds, as well as
monitor the movement and coalescence of individual aggregates into larger structures. This
method can be applied to diverse experimental systems, including live animals, and may
prove valuable for understanding cellular responses and diseases associated with protein
aggregates.
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P
roteins are involved in every aspect of cellular function and
homoeostasis, playing enzymatic, structural or signalling
roles that are typically made possible when the polypeptide
folds into a particular three-dimensional conformation. However,
proteins do not always achieve their folded conformations during
protein synthesis, and are folded; mature proteins may be readily
damaged by various types of environmental stresses such as heat
and oxidative stress. Misfolded proteins often lose the ability to
perform their intended functions, and in some cases misfolded
proteins can acquire new pathological functions. Thus, cells have
developed a variety of mechanisms to deal with misfolded
proteins and utilize a signiﬁcant amount of energy to maintain
cellular protein homoeostasis1.
Cells attempt to cope with misfolded proteins using two
major pathways: the protein refolding and degradation2,3.
Deﬁcient protein homoeostasis is strongly associated with neuro-
degenerative diseases including Alzheimer’s disease, Huntington’s
disease, amyotrophic lateral sclerosis and Parkinson’s disease1,4.
It is widely recognized that protein aggregation is often associated
with neurodegenerative diseases, and is also strongly associated
with aging. For these reasons, one potential therapeutic strategy
for treating neurodegenerative and other age-related diseases is to
prevent the formation of protein aggregates by modulating
protein homoeostasis4,5.
Although protein aggregates are associated with a wide variety
of diseases, we do not yet understand the mechanisms underlying
protein aggregation, including how cellular aggregates are
formed, how they are cleared, how other cellular proteins are
involved in aggregate formation and clearance or why oligomers
and aggregates are toxic to cells6. Many studies have used forceful
perturbations, such as heat shock and proteasome inhibition to
generate aggregates7,8. However, these stressors are extremely
strong and nonspeciﬁc, concomitantly inducing global cellular
stress responses unrelated to protein aggregation9. Others have
studied aggregates using genetic perturbations including polyQ-
fused mutant Huntingtin (Htt) proteins10,11. Despite higher
speciﬁcity, these systems display relatively little control over the
timing of aggregate onset or extent of aggregate formation.
In this study, we describe a novel small molecule-dependent
engineered protein that can be used to rapidly create protein
aggregates in cells with a high degree of spatial and temporal
control. The ability to regulate the formation of aggregates should
enable advances in our understanding of how protein aggregation
affects protein homoeostasis in cells.
Results
Development of chemically controllable protein aggregates. To
develop a conditional system to generate protein aggregates in
cells, we utilized destabilizing domain (DD) technology developed
by our group12–14. This technology was ﬁrst developed as a
method to regulate the metabolic stability of any protein of
interest using a cell-permeable ligand in conjunction with a
genetically encoded DD domain. We found that these DDs
confer instability to any fused-partner proteins and cause proteas-
ome-mediated degradation of the entire fusion protein12–14.
High-afﬁnity ligands bind to and stabilize these DD-fused
proteins in a dose-dependent manner12–14. Previous biophysical
studies showed that DDs possess a interesting property; the
folding state of the DD can be reversibly regulated by the
presence or absence of the ligand15. We took advantage of this
behaviour to interrogate the cellular protein quality-control
surveillance mechanisms using DDs as model substrates for
unstable proteins16,17.
To develop a new tool to study the mechanisms of protein
aggregation and its effects on cells, we engineered new DDs
derived from the human FK506 binding protein 12 (FKBP12)
protein (Fig. 1a). The hydrophobicity of N-terminal nuclear
export signals (NES) has been previously shown to be a critical
factor for aggregation18. Thus, we constructed several variations
of ﬂuorescently tagged DDs with NES sequences fused to their N
termini (Supplementary Fig. 1a). These NES-tagged DDs were
stably expressed in HEK293 cells, and we observed that one of
these DDs, which we call aggregating destabilizing domain
(AgDD), aggregates when the stabilizing ligand (Shield-1 or S1) is
withdrawn from the cell-culture media.
Beginning with the N terminus, the AgDD comprised of a
10-amino-acid NES sequence (LALKLAGLDI) derived from a
cAMP-dependent protein kinase inhibitor, an FKBP-derived DD
(L106P) followed by superfolder green ﬂuorescent protein (GFP).
When cells expressing AgDD are cultured in medium containing
S1, the speciﬁc ligand for FKBP-based DDs, AgDD is distributed
uniformly in the cells. However, after removing S1 from the
culture medium for 150min, AgDD coalesced into aggregates in
cells (Fig. 1b). This phenomenon of aggregation was also
observed in other cell lines, including NIH3T3 and U2OS cells
(Supplementary Fig. 1b,c).
To further characterize the time-dependent nature of AgDD
aggregation, we collected cells expressing high levels of AgDD by
ﬂow cytometry and monitored the behaviour of the AgDD
protein using epiﬂuorescence time-lapse microscopy. When cells
are cultured with S1, GFP is uniformly distributed throughout
these cells with no visible aggregates (Fig. 1c and Supplementary
Movie 1). When S1 is withdrawn from the culture media, AgDD
rapidly unfolds and forms small aggregates (Fig. 1c and
Supplementary Movie 2). On closer examination, the formation
of small, mobile aggregates commences within minutes of ligand
withdrawal (Fig. 1d and Supplementary Movie 3), and the small
aggregates coalesce into larger immobile aggregates over time.
Quantiﬁcation of the aggregates reveals that the cellular area
occupied by single aggregates increases in time-dependent
manner (Supplementary Fig. 1d), and the total number of
aggregates decreases once aggregates appeared (Supplementary
Fig. 1e).
Aggregates were allowed to form for 1 h and then S1 was
re-introduced into the culture media, leading to the
re-appearance of diffuse GFP signal by the 2-h time point
(Fig. 1c and Supplementary Movie 4). The addition of
cycloheximide along with S1 at the 1-h time point did not
prevent or signiﬁcantly attenuate the growth the diffuse GFP
signal (Supplementary Fig. 1f), suggesting that newly synthesized
AgDD-GFP is not the primary source of the diffuse GFP signal.
These results demonstrate that AgDD is a chemically controllable
protein that enables the rapid and pervasive induction of protein
aggregation with high-temporal resolution. Another advantage of
using the FKBP-based DD is that the S1 ligand does not induce
global stress responses produced by stimuli like proteasome
inhibitors or heat shock17,19.
We next monitored the aggregation of AgDD using analytical
ﬂow cytometry by collecting AgDD-expressing HEK293 cells at
different time points after S1 removal, and subjecting these
samples to analysis using the PulSA method20. Cells with
aggregates displayed narrowly distributed ﬂuorescent signals
compared with cells that did not have these punctate structures
(Supplementary Fig. 2a). Consistent with the time-lapse
microscopy experiments, we found that the population of cells
that contained aggregates continuously increased following
withdrawal of the ligand (Supplementary Fig. 2b).
AgDD aggregates resemble known aggregates. To further
examine the structure of aggregates, we used transmission
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electron microscopy (TEM) to visualize negatively stained cells
expressing the AgDD-GFP fusion protein. Consistent with the
results from ﬂuorescent microscopy, when S1 is withdrawn from
the culture media, AgDD forms large, electron-dense aggregates
(Fig. 2a,b; Supplementary Fig. 2c,d). The ultrastructural char-
acteristics of the aggregated AgDD-GFP resemble known ﬁla-
mentous aggregated proteins, such as the DF508 mutant of cystic
ﬁbrosis transmembrane conductance regulator (CFTR)21.
We also monitored localization of the endogenous
p62/SQSTM protein, a well-characterized marker for selective
autophagy that is known to colocalize with aggregates3.
Immunoﬂuorescence staining of AgDD and p62 showed that
p62 appears to colocalize with AgDD aggregates, although we
observe colocalization only after AgDD has been allowed to
aggregate for some time only at later times (5 h following S1
withdrawal, Fig. 2c).
AgDD aggregates affect cellular ﬁtness. Next, we examined the
effects of aggregated AgDD on cell growth and viability. For this
purpose, we devised a co-culture proliferation experiment in
which HEK293 cells expressing AgDD were co-cultured with
control HEK293 cells expressing only mCherry in media
containing S1. We withdrew S1 to induce AgDD aggregation and
analyzed the number of AgDD-positive cells relative to control
cells using ﬂow cytometry. Cell expressing the aggregated AgDD
proliferated more slowly than control cells but only after a full
day of aggregate induction (Fig. 3a and Supplementary Fig. 3a),
similar to results from experiments using polyQ aggregates22.
Aggregates formation depends on the amount of AgDD. We
next asked if aggregate formation is sensitive to the intracellular
concentration of the AgDD protein. We sorted HEK cells
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Figure 1 | Development of AgDD to rapidly create protein aggregates in living cells. (a) Schematic representation of inducing aggregated proteins inside
cells using an AgDD. (b) Images of representative HEK cells stably expressing AgDD before and after S1 washout (WO) for 150min. Scale bar, 10 mm.
(c) Time-lapse images of representative HEK cells stably expressing AgDD. Top: cells cultured in media with S1 throughout the experiment; middle: cells
cultured in media with S1 withdrawn at 0 h and bottom: cells cultured in media with S1 withdrawn from 0–1 h then readministered from 1–8 h. Scale bars,
20mm. (d) Early time-lapse images of representative HEK cells stably expressing AgDD following S1 withdrawal. Scale bar, 20mm.
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stably expressing AgDD into four groups on the basis of their
S1-stabilized GFP levels: high, high-med, med-low and low
(Supplementary Fig. 3b). By counting the numbers of cells with
aggregates 10min after withdrawal of S1, we observed that cells
expressing higher levels of AgDD are more likely to form
aggregates (high, 100%; medium-high, 95%; medium-low, 81%
and low, 48%, (Supplementary Fig. 3c), suggesting that the
formation of AgDD aggregates depends on the concentration of
AgDD.
Spatial control using a nuclear-localized AgDD. In order to
provide spatial resolution, we next attempted to induce AgDD
aggregate formation in speciﬁc cellular compartments. Protein
aggregates within the nucleus are associated with neurodegen-
erative diseases, so we ﬁrst targeted the AgDD-GFP fusion
protein to the cell nucleus by fusing a nuclear localization signal
to the N terminus of the AgDD construct23. When cells
expressing nuclear AgDD are cultured in medium with S1, the
GFP signal is diffusely localized in the nucleus (Fig. 3b and
Supplementary Movie 5). We observed the formation of multiple,
small AgDD aggregates immediately after S1 withdrawal
(Fig. 3b,c; Supplementary Movies 6 and 7). These small
aggregates appeared to be mobile within the cell nucleus and
they coalesced somewhat but did not become one large aggregate
in contrast to the behaviour of the cytosolic AgDD (Fig. 3b,c;
Supplementary Movies 6 and 7). Similar results were obtained
when AgDD-GFP was expressed in NIH3T3 cells (Supple-
a
S1
AgDD p62 Hoechst Merge
WO
60 min
WO
150 min
WO
300 min
c
b
5 µm 1 µm 
Figure 2 | AgDD aggregates have similar characteristics as ﬁlamentous aggregates. (a) TEM image of representative HEK cells stably expressing AgDD
after S1 washout for 60min. Scale bar, 5 mm. (b) Magniﬁed TEM image of white box inset in a. Scale bar, 1mm. (c) Immunoﬂuorescence images of
representative cells stably expressing AgDD-GFP before and after S1 removal for the indicated times. Left: AgDD; middle-left: p62; middle-right: Hoechst;
right: merge. Scale bars, 10mm. Texas-Red was used to label the p62 antibody.
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Figure 3 | Applications of AgDD. (a) HEK293 cells expressing AgDD and HEK293 cells expressing mCherry were mixed and co-cultured in media
containing S1. S1 was withdrawn for the indicated times, and cell populations were quantiﬁed using ﬂow cytometry. Replicates of n¼ 3. Error bar is Standard
Deviation (STD). (b) Time-lapse images of representative HEK293 cells stably expressing Nuclear AgDD. Top: cells cultured in media with S1 throughout
the experiment; bottom: cells cultured in media with S1 withdrawn at 0 h. Scale bars, 5 mm. (c) Early time-lapse images of representative HEK293 cells
stably expressing nuclear AgDD following S1 removal. Scale bar, 5mm. (d–g) Images of representative nematodes expressing AgDD in intestinal cells. Top
left: no S1; top right: 50mM S1, bottom left: S1 removed for 2 h, bottom right: S1 removed for 6 h. Scale bar, 50mm.
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mentary Fig. 3d). These results demonstrate that AgDD can be
used to investigate aggregate formation in speciﬁc subcellular
compartments.
AgDD induces aggregates in live animals. Finally, we used
C. elegans to test if our AgDD system can be used to conditionally
induce aggregate formation in vivo. We expressed AgDD in the
intestinal cells of C. elegans using the vha-6 promoter. Under
normal growth conditions without the stabilizing S1, we did not
observe AgDD signal suggesting that the AgDD fusion protein is
efﬁciently degraded as it is when expressed in mammalian cells
(Fig. 3d). When worms were grown on plates made with 50 mM
S1, the stabilized AgDD-GFP is observed as a diffuse signal in the
intestinal cells (Fig. 3e). When worms expressing stabilized
AgDD-GFP were transferred to plates lacking S1, the AgDD
started to form aggregates (Fig. 3f,g). The onset of the AgDD
aggregation was slower than was observed in cultured cells,
possibly because of slower rates of S1 clearance in live animals.
Formation of the AgDD aggregates typically began in the anterior
intestinal cells (arrow in Fig. 3f). Another interesting observation
was that the larger aggregates tend to colocalize with the auto-
ﬂuorescence signals from gut granules (data not shown), which
have been suggested to function as an aggresome-like region in
intestinal cells24.
Discussion
In summary, we developed a system for inducing and monitoring
protein aggregates in cells using a small cell-permeable molecule.
Compared with previous methods used to study aggregates,
AgDD has several advantages: it has fewer off-target effects, it can
be precisely regulated both spatially and temporally, and it has
low toxicity for cells. Small-protein aggregates are immediately
induced following withdrawal of the stabilizing ligand. Thus, this
system should enable detailed mechanistic investigations of the
mechanisms of the cellular response to protein aggregation. The
results also demonstrate that aggregates have similar character-
istics as the known ﬁlamentous aggregates from TEM and also
with p62, a well-known marker for aggregates, appears to
associate with the AgDD aggregates at a later stage. One possible
explanation for small aggregates could be Q-bodies, which was
found in yeast25.
Furthermore, we demonstrated that the AgDD protein can be
used in living organisms, such as the nematode, C. elegans, and
that aggregate formation could be restricted to speciﬁc cellular
compartments such as the nucleus. Although further investiga-
tion is required, the behaviour of AgDD-derived aggregates in the
nucleus appeared to differ from cytosolic aggregates, perhaps
reﬂecting different protein quality-control surveillance mechan-
isms between these compartments23. This system will be
extremely useful to investigate nuclear protein-quality control
because nuclear protein misfolding and aggregation are strongly
associated with the pathology of neurodegenerative diseases23.
Given the high degree of control inherent in this method, the
AgDD constructs may be useful in a discovery screening format
to identify potential agents capable of modulating protein
aggregate production.
Methods
Cloning. FKBP-derived AgDDs were cloned into Piggybac Transposon System pB
vectors as N-terminal fusions to a SuperFolder GFP. For C. elegans studies, FKBP-
derived AgDDs were fused to the N terminus of sfGFP, and this construct was
cloned into a pSM vector where expression of the fusion protein was driven by the
a vha-6 promoter.
Cell culture, transfections and transductions. The NIH3T3 cell lines were
cultured in DMEM supplemented with 10% heat-inactivated donor bovine serum
(Invitrogen), 2mM glutamine, 100Uml-1 penicillin and 100 mgml-1 streptomycin.
The HEK293 cell lines and U2OS cell lines were cultured with 10% heat-inactivated
foetal bovine serum (Invitrogen), 2mM glutamine, 100Uml-1 penicillin and
100 mgml-1 streptomycin.
To establish AgDD-expressing cell lines, cells were plated at 10 104 cells per
well of a 6-well plate a day before transfection. The cells were co-transfected
with plasmids of a pB vector and PiggyBac transposase vector following standard
protocols using TransIT-LT1 (Mirus). After the cells were cultured in growth
media for about a week to allow stable integration, the transfected cells were sorted
by ﬂow cytometry for high-GFP level cells.
Withdrawal of Shield-1. To remove the Shield-1 (S1) ligand from media
containing Shield-1, we directly added puriﬁed FKBP(F36V) protein (350–500 mM
stock) in cultured media to achieve a ﬁnal cellular protein concentration of
3.5–5 mM. The presence of extracellular FKBP creates a strong thermodynamic sink
facilitating the removal of S1 from stabilizing the intracellular AgDD.
Flow cytometry. Cells were trypsinized and resuspended in culture media before
undergoing FACS sorting at the Stanford Shared FACS Facility using BD Aria II.
For analytical ﬂow cytometry, cells were trypsinized and resuspended in culture
media before analysis using a BD FACS Calibur with no less than 10,000 events
represented. Data were analyzed using FlowJo.
Live-cell imaging. Time-lapse imaging was performed with a Nikon Eclipse Ti
ﬂuorescence microscope using mManager (https://www.micro-manager.org/). Cells
were prepared on an 8-well Nunc Lab-Tek Chambered Coverglass (Thermo
Scientiﬁc) coated with poly-Lysine (Invitrogen). During time-lapse experiments,
the same conditions were maintained including a temperature of 37 C and a CO2
concentration of 5%. Other live-cell images were captured on a Zeiss Axioskop 2
epiﬂuorescence microscope equipped with a QICAM FAST 1,394 digital CCD
camera.
Immunoﬂuorescence. Following ﬁxation in PBS with 4% paraformaldehyde
(Ted Pella) for 20min, cells were permeabilized using PBS with 0.2% Triton-X
(Sigma) for 15min and incubated in 3% BSA (Sigma-Aldrich) in PBS for 60min.
p62 antibody (mouse, used at 1:400, BD Biosciences 610,832) incubation was
carried out at 4 C overnight followed by Alexa Fluor-conjugated secondary anti-
bodies for 1 h at room temperature (1:1,000; Life Technologies) and Hoechst
33,342 (1:10,000; Life Technologies). Images were acquired on a custom-assembled
spinning disk confocal system built around an inverted Zeiss Axiovert 200M
microscope with three lasers (442, 514 and 593.5 nm) and a CoolSNAP CCD
camera from Photometrics/Roper Scientiﬁc. Imaging was carried out on an
integrated ImageXpress (Molecular Devices) high-content analysis system.
C. elegans studies. C. elegans strain was maintained as previously described26.
Transgenic strains were generated by injecting Pvha-6::AgDD-GFP and Podr-
1::RFP plasmids into Bristol N2 strain by standard injection methods27. Images of
ﬂuorescently tagged fusion proteins were captured in live C. elegans using a Zeiss
LSM710 confocal microscope (Carl Zeiss). Worms were immobilized on a 2%
agarose pad with 10mM levamisole (Sigma-Aldrich). Images were analyzed with
Zen software (Carl Zeiss).
Bioinformatic analysis. All statistical analyses were performed in R (www.rpro-
ject.org) or Prism 6. All cell image analyses were done using MATLAB and imageJ
(http://imagej.nih.gov/ij/).
Quantiﬁcation of aggregates. The Haar Wavelet transform was applied once to
extract the high-frequency image, and this image was resized to its original size
with bi-cubic interpolation. It was then subtracted from the original image, which
represents the low frequency part of the image. Preliminarily, the illumination of
the image was corrected using the similar approach with seven levels of decom-
position. These implementations remove noise but retain the aggregates with
various size. To identify puncta of various intensity, 2D Gaussian ﬁlter was applied
to the transformed image, and then if a pixel in the transformed image has 20%
larger value than the corresponding pixel in the Gaussian-smoothed image, it was
classiﬁed as aggregates. This binarized image was further masked by a background
region, which was simply determined by a threshold of a constant value.
The average aggregates area and a number of aggregates over time were
extracted from the binarized image, and then the mean and standard deviations
were calculated from ﬁve different ﬁelds of views. If a number of aggregates was
o100 in one ﬁeld of view, the average area was set to 0 in order to suppress an
error from segmentation, meaning no aggregates were observed in the image.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author upon request.
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